Skip to main content

Extraordinary BioMed Seminar - Regulation of Hematopoietic Stem Cell Dormancy


Organizer: IRB BioMed Seminars

Speaker: Dr. Nina Cabezas-Wallsheid, PhD  - Group Leader, Max-Planck Institute of Immunobiology and Epigenetics (MPI-IE),  | Freiburg, Germany. Principal Investigator, Center for Integrative Biological Signaling Studies (CIBSS), German Cluster of Scientific Excellence, University of Freiburg

Date: Monday, 6 March 2023 at 12PM

Place: Auditorium, PCB

Host: Alejo Rodriguez-Fraticelli, Ph.D - Group Leader , Quantitative Stem Cell Dynamics, Aging and Metabolism Programme.



Bone marrow hematopoietic stem cells (HSCs) are vital for the maintenance of hematopoiesis. In inbred mice housed in gnotobiotic facilities, the top of the hematopoietic hierarchy is occupied by dormant HSCs, which reversibly exit quiescence during stress. Still, whether HSC dormancy exists in human remains unclear. Our recent work shows the existence and relevance of dormancy in human HSCs and identifies the hyaluronic acid-GPRC5C signalling axis as an essential component controlling the HSC state (Zhang et al., Nature Cell Biology 2022). Further, HSCs rely on complex regulatory networks to preserve their function. Due to the scarcity of HSCs, technical challenges have limited their insights into the interplay between HSC metabolism and their transcriptional and epigenetic regulation. They recently established and integrated low-input multi-layer OMICs data revealing distinct metabolic and epigenetic hubs that are enriched in HSCs and their downstream multipotent progenitors (Schönberger et al., Cell Stem Cell 2022). Mechanistically, they uncover a non-classical retinoic acid signaling axis that regulates HSC identity. Their findings emphasize how a single metabolite controls stem cell fate by instructing epigenetic and transcriptional attributes




IRB BioMed Seminars

IMPORTANT: For attendees outside the PCB community you must register at least 24h before the seminar.